Clinical trials (CT) — a systematic study of the drug through the use of it at the person (patient or healthy volunteer) in order to assess its safety and / or efficiency, as well as identifying and / or confirmation of its clinical, pharmacological, and pharmacodynamic properties, evaluation of absorption, distribution, metabolism, excretion and / or interactions with other drugs.
The company «AiLFARMA» conducts all phases of clinical trials:

Phase I — clinical pharmacological trials. They are designed in such a way as to set the tolerance, safety, availability of therapeutic action, pharmacokinetic and pharmacodynamic properties. Such studies are conducted on healthy people (volunteers).
Phase II — efficacy and safety of the drug in patients with a specific disease. Usually it is a placebo-controlled study. Sometimes a Phase II clinical trials are divided into phase IIa and Iib. The objectives of Phase II is a short-term safety evaluation of medicinal product (IIa), as well as evidence of clinical efficacy of the drug and determine the therapeutic dose level when tested on a group of patients (Iib).
Phase III — evaluation of efficacy and safety of LP in conditions close to actual practice. Phase III trials are often randomized controlled trials. In these studies, we study all aspects of treatment, including assessment of indicators of risk / benefit. Based on the results of Phase III clinical trial decision on registration or refusal to register the drug. Phase III clinical trial can also be divided into phases IIIa and IIIb.
Phase IV — postmarketing (postmarketing) studies. The purpose of this research is to identify the differences between a new drug from other drugs in this farmgruppe, comparing its effectiveness to peers, already implemented in the market and demonstration of the new drug benefit in terms of health economics, as well as detection and identification of previously unknown or incorrectly identified adverse effects of the drug and risk factors. As a result, safety and efficacy of drugs may be reviewed periodically in line with new clinical data on its use

Guarantee 100%
Ready to contact us?

Our managers will provide you with exhaustive information and will answer any questions
• We will contact you in some minutes and will provide additional details about the process of obtaining the necessary documents
Thank you! Your request has been sent!
Our specialists will be in contact with you very soon

An error occurred

Your request has not been sent. Sorry, try later.

About a company

Contact us and we will take care of the rest for you


Address: c. Moscow, 2-й Syromyatnicheskiy str., д.1
Phone: +7(495)665-81-35
Address: г. Kazan, Pr. Yamasheva 46/33
Phone: 8 (843) 226-03-63 ,
WhatsApp: +7(495)665-81-35
Skype: ailfarma@mail.ru

AiLFarma - licensing of medicines
Работает на HostCMS